Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors

Fried David V.; Mawlawi Osama; Zhang Lifei; Fave Xenia; Zhou Shouhao; Ibbott Geoffrey; Liao Zhongxing; Court Laurence E.

首页> 外文期刊>Radiology >Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors

【24h】

Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors

机译：III期非小细胞肺癌：FDG PET定量成像特征与临床预后因素相结合的预后价值

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose: To determine whether quantitative imaging features from pretreatment positron emission tomography (PET) can enhance patient overall survival risk stratification beyond what can be achieved with conventional prognostic factors in patients with stage III non-small cell lung cancer (NSCLC).

机译：目的：确定来自治疗前正电子发射断层扫描（PET）的定量成像特征是否可以增强患者的总体生存风险分层，使其超过III期非小细胞肺癌（NSCLC）患者的常规预后因素所能达到的水平。

著录项

来源
《Radiology》 |2016年第1期|共9页
作者
Fried David V.; Mawlawi Osama; Zhang Lifei; Fave Xenia; Zhou Shouhao; Ibbott Geoffrey; Liao Zhongxing; Court Laurence E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors [J] . Fried David V., Mawlawi Osama, Zhang Lifei, Radiology . 2016,第1期

机译：III期非小细胞肺癌：FDG PET定量成像特征与临床预后因素相结合的预后价值
2. Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors [J] . Kang Yeon-koo, Song Yoo Sung, Cho Sukki, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2018,第期

机译：手术切除术治疗阶段I期非小细胞肺癌腺癌患者的预后分层模型，无佐剂疗法在F-18 FDG宠物和术后病理因子上测量的代谢特征
3. Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy [J] . Kewei Zhao, Chunsheng Wang, Fang Shi, BMC Cancer . 2021,第1期

机译：源自FDG-PET的SUVMAX的组合预后值和IIIB-IV阶段非小细胞肺癌接受化疗的患者淋巴细胞单核细胞比
4. FDG uptake as a biological prognostic factor for recurrence in patients with surgically resected stage Ⅰ non-small cell lung cancer [C] . The First China-Japan-Korea conference of nuclear medicine . 2002

机译：手术切除的Ⅰ期非小细胞肺癌患者FDG摄取是复发的生物学预后因素
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Stage III Non–Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors [O] . David V. Fried, Osama Mawlawi, Lifei Zhang, -1

机译：III期非小细胞肺癌：FDG PET定量成像特征与临床预后因素相结合的预后价值
7. Prognostic value of various metabolic parameters on pre-treatment 18-F-FDG PET/CT in patients with stage I-III non-small cell lung cancer [O] . F. Demir, A. Yanarateş 2020

机译：在I-III期非小细胞肺癌患者中治疗前18-F-FDG PET / CT的各种代谢参数的预后价值

Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅